β-catenin mutation is selected during malignant transformation in colon carcinogenesis

Carcinogenesis

Volumn 24, Issue 1, 2003, Pages 91-97

  Yamada, Yasuhiro ^a   Oyama, Takeru ^a   Hirose, Yoshinobu ^a   Hara, Akira ^a   Sugie, Shigeyuki ^a   Yoshida, Koujiro ^a   Yoshimi, Naoki ^b   Mori, Hideki ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZOXYMETHANE; BETA CATENIN; DNA; ONCOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CODON; COLON INJURY; COLON MUCOSA; COLON TUMOR; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE MODEL; DISSECTION; DNA DETERMINATION; EXON; GENE ACTIVATION; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC CODE; GENETIC SELECTION; HISTOPATHOLOGY; MALE; MALIGNANT TRANSFORMATION; NONHUMAN; ONCOGENE K RAS; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; RAT STRAIN; SIGNAL TRANSDUCTION;

ANIMALS; BASE SEQUENCE; BETA CATENIN; CELL TRANSFORMATION, NEOPLASTIC; COLONIC NEOPLASMS; CYTOSKELETAL PROTEINS; GENES, RAS; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR SEQUENCE DATA; MUTATION; RATS; RATS, INBRED F344; TRANS-ACTIVATORS;

EID: 0037278584     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/24.1.91     Document Type: Article

References (28)

1. Vogelstein,B., Fearon,E., Hamilton,S., Kern,S., Preisinger,A., Leppert,M., Nakamura,Y., White,R., Smits,A. and Bos,J. (1988) Gedetic alterations during colorectal-tumor development. N. Engl. J. Med., 319, 525-532.
2. Powell,S., Zilz,N., Beazer-Barclay,Y., Bryan,T., Hamilton,S., Thibodeau,S., Vogelstein,B. and Kinzler,K. (1992) APC mutations occur early during colorectal tumorigenesis. Nature, 359, 235-237.
3. Polakis,P. (1997) The adenomatous polyposis coli (APC) tumor suppressor. Biochim. Biophys. Acta, 1332, F127-F147.
4. Takahashi,M., Fukuda,K., Sugimura,T. and Wakabayashi,K. (1998) β-Catenin is frequently mutated and demonstrates altered cellular location in azoxymethane-induced rat colon tumors. Cancer Res., 58, 42-46.
5. Aberle,H., Bauer,A., Stappert,J., Kispert,A. and Kemler,R. (1997) β-Catenin is a target for the ubiquitin-proteasome pathway. EMBO J., 16, 3797-3804.
6. Morin,P., Sparks,A., Korinek,V., Barker,N., Clevers,H., Vogelstein,B. and Kinzler,K. (1997) Activation of β-catenin -Tcf signaling in colon cancer by mutations in β-catenin or APC. Science, 275, 1787-1790.
7. Molenaar,M., Wetering,M.v.d., Oosterwegel,M., Peterson-Maduro,J., Godsave,S., Korinek,V., Roose,J., Destree,O. and Clevers,H. (1996) XTcf-3 transcription factor mediates β-catenin-induced axis formation in Xenopus embryos. Cell, 86, 391-399.
8. Behrens,J., Kries,J.v., Kuhl,M., Bruhn,L., Wedlich,D., Grosschedl,R. and Birchmeier,W. (1996) Functional interaction of β-catenin with the transcription factor LEF-1. Nature, 382, 638-642.
9. He,T., Sparks,A., Rago,C., Hermeking,H., Zawel,L., Costa,L.D., Morin,P., Vogelstein,B. and Kinzler,K. (1998) Identification of c-MYC as a target of the APC pathway. Science, 281, 1509-1512.
10. Tetsu,O. and McCormick,F. (1999) β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature, 398, 422-426.
11. Bos,J.L., Fearon,E.R., Hamilton,S.R., Verlaan-de Vries,M., van Boom,J.H., van der Eb,A.J. and Vogelstein,B. (1987) Prevalence of ras gene mutations in human colorectal cancers. Nature, 327, 293-297.
12. Shirasawa,S., Furuse,M., Yokoyama,N. and Sasazuki,T. (1993) Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. Science, 260, 85-88.
13. Yamada,Y., Yoshimi,N., Hirose,Y., Kawabata,K., Matsunaga,K., Shimizu,M., Hara,A. and Mori,H. (2000) Frequent β-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis. Cancer Res., 60, 3323-3327.
14. Yamada,Y., Yoshimi,N., Hirose,Y. and Mori,H. (2001) Sequential analysis of morphological and biological properties of β-catenin-accumulated crypts, provable preneoplastic lesions independent of aberrant crypt foci in rat colon carcinogenesis. Cancer Res., 61, 1874-1878.
15. Harada,N., Tamai,Y., Ishikawa,T., Sauer,B., Takaku,K., Oshima,M. and Taketo,M. (1999) Intestinal polyposis in mice with a dominant stable mutation of the β-catenin gene. EMBO J., 18, 5931-5942.
16. Bird,R.P. (1995) Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett., 93, 55-71.
17. Yamada,Y., Yoshimi,N., Hirose,Y., Hara,A., Shimizu,M., Kuno,T., Katayama,M., Zheng,Q. and Mori,H. (2001) Suppression of occurrence and advancement of β-catenin-accumulated crypts, possible premalignant lesions of colon cancer, by selective cyclooxygenase-2 inhibitor, celecoxib. Jpn J. Cancer Res., 92, 617-623.
18. Dubois,R., Abramson,S., Crofford,L., Gupta,R., Simon,L., Putte,L.V.D. and Lipsky,P. (1998) Cyclooxygenase in biology and disease. FASEB J., 12, 1063-1073.
19. Shiff,S. and Rigas,B. (1999) The role of cyclooxygenase inhibition in the antineoplastic effects of nonsteroidal anti-inflammatory drugs (NSAIDs). J. Exp. Med., 190, 445-450.
20. Kawamori,T., Rao,C., Seibert,K. and Reddy,B. (1998) Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res., 58, 409-412.
21. Rao,C.V., Hirose,Y., Indranie,C. and Reddy,B.S. (2001) Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids. Cancer Res., 61, 1927-1933.
22. Kawabata,K., Tanaka,T., Murakami,T., et al. (1999) Dietary prevention of azoxymethane-induced colon carcinogenesis with rice-germ in F344 rats. Carcinogenesis, 20, 2109-2115.
23. Suzui,M., Yoshimi,N., Dashwood,R., Ushijima,T., Sugimura,T., Mori,H. and Nagao,M. (1999) Frequent mutations in the rat β-catenin gene (Ctnnb1) of ulcerative colitis-associated colon cancer induced by 1-hydroxy-anthraquinone and methylazoxymethanol acetate. Mol. Carcinog., 24, 232-237.
24. Orford,K., Crockett,C., Jensen,J., Weissman,A. and Byers,S. (1997) Serine phosphorylation-regulated ubiquitination and degradation of β-catenin. J. Biol. Chem., 272, 24735-24738.
25. 6-methylguanine by alkylation of rat liver, colon and kidney DNA following administration of 1,2-dimethylhydrazine. Cancer Res., 37, 4082-4087.
26. Pretlow,T.P., Barrow,B.J., Ashton,W.S., O'Riordan,M.A., Pretlow,T.G., Jurcisek,J.A. and Stellato,T.A. (1991) Aberrant crypts: putative preneoplastic foci in human colonic mucosa. Cancer Res., 51, 1564-1567.
27. Jen,J., Powell,S.M., Papadopoulos,N., Smith,K.J., Hamilton,S.R., Vogelstein,B. and Kinzler,K.W. (1994) Molecular determinants of dysplasia in colorectal lesions. Cancer Res., 54, 5523-5526.
28. Pretlow,T.P., Brasitus,T.A., Fulton,N.C., Cheyer,C. and Kaplan,E.L. (1993) K-ras mutations in putative preneoplastic lesions in human colon. J. Natl Cancer Inst., 85, 2004-2007.